StockData
MariMed Inc. logo

MariMed Inc. (MRMD) stock

MRMDOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.06−0.00 (-3.39%)

Close on Oct 19, 2026Market cap $22.97MP/E –Yield –

MariMed gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

MariMed's gross profit for the twelve months ending Sep 30, 2026 was $59.16M, down 1.5% year over year. For fiscal 2025 it was $57.88M, down 7.6% from the year before. The highest annual figure on record is $66.26M in fiscal 2021.

Annual gross profit

PeriodPeriod endValueChange
FY2025Dec 31, 2025$57.88M-7.6%
FY2024Dec 31, 2024$62.61M-5.0%
FY2023Dec 31, 2023$65.92M+3.1%
FY2022Dec 31, 2022$63.96M-3.5%
FY2021Dec 31, 2021$66.26M+111.5%
FY2020Dec 31, 2020$31.32M+67.5%
FY2019Dec 31, 2019$18.70M+139.4%
FY2018Dec 31, 2018$7.81M+101.6%
FY2017Dec 31, 2017$3.88M+99.1%
FY2016Dec 31, 2016$1.95M–
FY2015Dec 31, 2015-$296.65K–
FY2014Dec 31, 2014-$101.78K–
FY2013Dec 31, 2013-$25.38K–
FY2012Dec 31, 2012-$19.16K–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$17.16M+4.9%
Q2 FY2026Jun 30, 2026$16.23M+1.9%
Q1 FY2026Mar 31, 2026$15.28M+1.2%
Q4 FY2025Dec 31, 2025$10.50M-17.0%
Q3 FY2025Sep 30, 2025$16.36M-2.5%
Q2 FY2025Jun 30, 2025$15.93M-5.8%
Q1 FY2025Mar 31, 2025$15.09M-8.4%
Q4 FY2024Dec 31, 2024$12.66M-26.9%
Q3 FY2024Sep 30, 2024$16.78M-0.3%
Q2 FY2024Jun 30, 2024$16.91M+3.3%
Q1 FY2024Mar 31, 2024$16.47M+7.0%
Q4 FY2023Dec 31, 2023$17.32M+9.5%
Q3 FY2023Sep 30, 2023$16.84M+4.2%
Q2 FY2023Jun 30, 2023$16.38M+9.1%
Q1 FY2023Mar 31, 2023$15.39M-9.4%
Q4 FY2022Dec 31, 2022$15.81M+2.1%
Q3 FY2022Sep 30, 2022$16.16M+22.6%
Q2 FY2022Jun 30, 2022$15.01M+29.1%
Q1 FY2022Mar 31, 2022$16.98M+95.6%
Q4 FY2021Dec 31, 2021$15.49M+151.5%
Q1 FY2021Mar 31, 2021$13.19M+170.9%
Q4 FY2020Dec 31, 2020$11.62M+313.0%
Q3 FY2020Sep 30, 2020$8.68M+84.7%
Q2 FY2020Jun 30, 2020$6.16M-31.0%
Q1 FY2020Mar 31, 2020$4.87M+115.3%
Q4 FY2019Dec 31, 2019$2.81M+3.3%
Q3 FY2019Sep 30, 2019$4.70M+151.4%
Q2 FY2019Jun 30, 2019$8.93M+341.1%
Q1 FY2019Mar 31, 2019$2.26M+89.4%
Q4 FY2018Dec 31, 2018$2.72M+210.8%
Q3 FY2018Sep 30, 2018$1.87M+60.2%
Q2 FY2018Jun 30, 2018$2.02M+75.7%
Q1 FY2018Mar 31, 2018$1.19M+75.7%
Q4 FY2017Dec 31, 2017$876.11K+14.6%
Q3 FY2017Sep 30, 2017$1.17M+159.0%
Q2 FY2017Jun 30, 2017$1.15M–
Q1 FY2017Mar 31, 2017$679.65K–
Q4 FY2016Dec 31, 2016$764.75K–
Q3 FY2016Sep 30, 2016$450.83K–

More MariMed figures

See a number that looks wrong?